Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Immunology
[키워드] activated
acute respiratory distress
acute respiratory syndrome
Analysis
approved
assigned
causative pathogen
change
circulating neutrophil
circulation
Clinical deterioration
coronavirus
COVID-19
COVID-19 patient
death
develop
disease severity
dysregulated immune response
examined
Granulocytic
Hospital admission
immature
immune dysregulation
immunosuppressive
individual
lung
majority
Mild
moderate
NETs
neutrophil
neutrophil dysfunction
Neutrophil extracellular trap
Neutrophil extracellular traps
neutrophilic infiltrate
Neutrophils
occur
participant
Patient
phenotype
potential therapeutic target
prognostic
pulmonary failure
pulmonary immune response
respiratory complication
risk
robust
SARS-CoV-2
severe COVID-19
severe disease
shown
Single Cell
specific treatment
subset
Symptoms
syndrome
target
Treatment
[DOI] 10.3389/fimmu.2021.680134 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.680134 PMC 바로가기 [Article Type] Immunology